...
首页> 外文期刊>Journal of chromatography, B. Analytical technologies in the biomedical and life sciences >Quantitative analysis of 4β- and 4α?hydroxycholesterol in human plasma and serum by UHPLC/ESI-HR-MS
【24h】

Quantitative analysis of 4β- and 4α?hydroxycholesterol in human plasma and serum by UHPLC/ESI-HR-MS

机译:用UHPLC / ESI-HR-MS对4β-and4α的羟基胆固醇和血清的定量分析

获取原文
获取原文并翻译 | 示例

摘要

Cholesterol oxidation product 4β?hydroxycholesterol (4β?OHC) may possibly be used as an endogenous biomarker of CYP3A enzyme activity and as CYP3A4 is involved in the metabolism of approximately 50% of the drugs in clinical use, the monitoring of CYP3A activity by 4β?OHC plasma or serum levels, may be of clinical significance. The plasma and serum concentrations of 4α?hydroxycholesterol (4α?OHC), an isomer of 4β?OHC, increase during uncontrolled storage conditions and therefore serve as an indicator of proper handling of samples.A sensitive and simple high-throughput method for the simultaneous quantification of both 4α?OHC and 4β?OHC in human plasma and serum was developed utilizing ultrahigh performance liquid chromatography coupled with high resolution mass spectrometry (UHPLC/ESI-HR-MS). The chromatographic analysis was carried out on a Waters HSS T3 C18 reversed phase column with a mobile phase composed of 0,1% formic acid with 200?mg/l sodium acetate, and methanol. 4β?OHC and 4α?OHC and also internal standard d7?4β?OHC were monitored using HR-MS as sodium adducts, which could not be used as a precursor ions in conventional tandem mass spectrometry methods due to their extensive stability in collision for MS/MS. The use of HR-MS detection enabled avoiding laborious sample derivatization, which is required with triple quadrupole mass spectrometer-based methods to achieve adequate analytical sensitivity for 4β?OHC, as the underivatized molecule is otherwise poorly ionized to other molecular ions than sodium adduct. Chromatographic separation of 4α?OHC and 4β?OHC was obtained and confirmed with standard samples prepared in blank surrogate matrix. The lower limits of quantitation in the assay were 0.5?ng/ml for 4β?OHC, and 2?ng/ml for 4α?OHC. Endogenous levels of 4β?OHC can vary between 10 and 100?ng/ml depending on the possible induction or inhibition of CYP3A4, whereas the levels of 4α?OHC can vary between 5 and 100?ng/ml, depending on the stora
机译:胆固醇氧化产物4β?羟基胆固醇(4β≤HOHC)可能用作CYP3A酶活性的内源生物标志物,并且随着CYP3A4参与临床用途的约50%的药物的代谢,通过4β监测CYP3A活性的监测? OHC等离子体或血清水平,可能具有临床意义。 4αβ羟基胆固醇(4α.Ohc),4β的异构体,4β的异构体,在不受控制的储存条件下增加,因此是适当处理样品的指标。同时的敏感和简单的高通量方法使用高分辨率质谱(UHPLC / ESI-HR-MS),开发了人血浆和血清中的4α的定量和4β的人类血浆和血清中的OHC。通过由200μl2mg/ l乙酸钠和甲醇组成的0,1%甲酸,将色谱分析在水溶液HSS T3 C18反相柱上进行。 4β?OCC和4α?OCC以及内标准的D7?4β,使用HR-MS作为钠加合物监测OHC,其在常规串联质谱法中不能用作前体离子,这是由于它们对MS的碰撞的广泛稳定性/多发性硬化症。 HR-MS检测的使用使得避免了富有费力的样品衍生化,这是基于三重四极杆质谱仪的方法,以实现4β的适当分析敏感性,因为所然的分子否则与钠加合物的其他分子离子相对于其他分子离子很差。获得4α的色谱分离4α.OhC和4β的OCC并用在空白替代基质中制备的标准样品证实。测定中的测量中的较低限制为0.5〜Ng / ml,4βOO2 OHC,2→Ng / ml,4αΩOHC。 4β的内源性水平可根据CYP3A4的可能诱导或抑制而变化10至100μg/ mL,而4α的水平可以在5至100μg/ mL之间变化,这取决于斯库尔

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号